CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
OPERATING ACTIVITIES
Net income	$ 47,000,000	$ 11,300,000	$ 58,700,000
Adjustments to reconcile net income to net cash provided from operating activities:
Depreciation and amortization	117,800,000	119,300,000	122,300,000
Goodwill impairment charge	0	12,500,000	0
Non-cash excess inventory write-down	0	22,500,000	0
Non-cash restructuring and asset impairment charges	0	7,600,000	7,600,000
Deferred income taxes	41,600,000	800,000	60,400,000
Net pension expense	48,400,000	53,800,000	44,500,000
Payments from qualified pension plan associated with restructuring charges	0	9,400,000	8,300,000
Stock-based compensation expense	13,000,000	8,700,000	10,000,000
Net loss on disposal of property and equipment	2,500,000	600,000	1,200,000
Loss on divestiture of business	3,200,000	0	0
Changes in working capital and other:
Accounts receivable	(34,600,000)	48,200,000	25,400,000
Inventories	(74,600,000)	1,600,000	36,000,000
Other current assets	2,800,000	(2,100,000)	(300,000)
Accounts payable	42,500,000	(7,600,000)	(59,900,000)
Accrued liabilities	25,600,000	(14,000,000)	(12,100,000)
Pension plan contributions	(100,000,000)	0	(7,200,000)
Other postretirement plan contributions	(3,200,000)	(13,000,000)	(13,200,000)
Other, net	(2,700,000)	(2,700,000)	900,000
Net cash provided from operating activities	129,300,000	256,900,000	282,600,000
INVESTING ACTIVITIES
Purchases of property, equipment and software	(98,500,000)	(95,200,000)	(170,500,000)
Proceeds from disposals of property and equipment and assets held for sale	2,500,000	1,400,000	200,000
Acquisition of business	(35,300,000)	0	0
Proceeds from maturities of marketable securities	900,000	900,000	300,000
Net proceeds from divestiture of business	12,000,000	0	0
Proceeds from note receivable from the sale of equity method investment	6,300,000	0	0
Proceeds received from sale of equity method investment	0	6,300,000	0
Other	0	4,000,000	0
Net cash used for investing activities	(112,100,000)	(82,600,000)	(170,000,000)
FINANCING ACTIVITIES
Credit agreement borrowings	122,100,000	77,000,000	545,100,000
Credit agreement repayments	(122,100,000)	(77,000,000)	(545,100,000)
Dividends paid	(34,100,000)	(34,800,000)	(37,900,000)
Payments of debt issue costs	(1,400,000)	0	0
Purchases of treasury stock	0	(123,900,000)	(124,500,000)
Payments on seller financed debt related to purchase of software	0	(4,900,000)	0
Tax benefits on share-based compensation	500,000	0	700,000
Proceeds from stock options exercised	2,200,000	500,000	2,300,000
Net cash used for financing activities	(32,800,000)	(163,100,000)	(159,400,000)
Effect of exchange rate changes on cash and cash equivalents	(100,000)	800,000	(3,200,000)
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(15,700,000)	12,000,000	(50,000,000)
Cash and cash equivalents at beginning of year	82,000,000	70,000,000	120,000,000
Cash and cash equivalents at end of year	$ 66,300,000	$ 82,000,000	$ 70,000,000